(Q54354737)

28 May 2018

title

The expression of β-catenin in different subtypes of breast cancer and its clinical significance. (English)

1 reference

28 May 2018

4

Li Li

1 reference

28 May 2018

Shuguang Li

1

1 reference

28 May 2018

Shanshan Li

series ordinal

2

1 reference

28 May 2018

Ying Sun

series ordinal

3

1 reference

28 May 2018

publication date

8 May 2014

1 reference

28 May 2018

published in

Tumor Biology

1 reference

28 May 2018

volume

35

1 reference

28 May 2018

issue

8

1 reference

28 May 2018

page(s)

7693-7698

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-014-1975-0

exact match

0 references

cites work

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Balancing cell adhesion and Wnt signaling, the key role of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Phospho-regulation of Beta-catenin adhesion and signaling functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Beta-catenin and Tcfs in mammary development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

beta-catenin is a target for the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Convergence of Wnt, beta-catenin, and cadherin pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Key signaling nodes in mammary gland development and cancer: β-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Wnt and mammary stem cells: hormones cannot fly wingless

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Method for grading breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Abnormal expression of Nek2 and β-catenin in breast carcinoma: clinicopathological correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Genome profiling of ERBB2-amplified breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1975-0

Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS)

21 January 2018

1 reference

12 December 2020

Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells

1 reference

12 December 2020

Wnt signaling and cancer

1 reference

12 December 2020

An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer

1 reference

12 December 2020

10.1007/S13277-014-1975-0

Identifiers

DOI

1 reference

28 May 2018

PubMed ID

24801904

1 reference

28 May 2018